Atlas Trials

Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency

Clinical trial NCT04098237 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04098237
Sponsor
Andrew Hendifar, MD
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2020-12-17
Primary completion
2024-01-12
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.